Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05187884
Title Neoadjuvant/Adjuvant Trial of Darovasertib in Ocular Melanoma (NADOM)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Anthony Joshua, FRACP
Indications
Therapies
Age Groups: adult | senior
Covered Countries


No variant requirements are available.